Singer DE - Search Results

1

Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AF.

Steinberg BA, Holmes DN, Pieper K, Allen LA, Chan PS, Ezekowitz MD, Freeman JV, Fonarow GC, Gersh BJ, Hylek EM, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Singer DE, Peterson ED, Piccini JP; ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Investigators and Patients. Steinberg BA, et al. Among authors: singer de. Circ Arrhythm Electrophysiol. 2020 May;13(5):e007775. doi: 10.1161/CIRCEP.119.007775. Epub 2020 Apr 16. Circ Arrhythm Electrophysiol. 2020. PMID: 32298144 Free PMC article.

2

The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.

Lancaster TR, Singer DE, Sheehan MA, Oertel LB, Maraventano SW, Hughes RA, Kistler JP. Lancaster TR, et al. Among authors: singer de. Arch Intern Med. 1991 Oct;151(10):1944-9. Arch Intern Med. 1991. PMID: 1929681 Clinical Trial.

3

Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study.

Fine MJ, Smith DN, Singer DE. Fine MJ, et al. Among authors: singer de. Am J Med. 1990 Dec;89(6):713-21. doi: 10.1016/0002-9343(90)90211-u. Am J Med. 1990. PMID: 2252039

4

Optimal oral anticoagulation for patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.

Singer DE, Hylek EM. Singer DE, et al. N Engl J Med. 1995 Nov 30;333(22):1504. doi: 10.1056/NEJM199511303332213. N Engl J Med. 1995. PMID: 7477157 No abstract available.

5

Risk factors for intracranial hemorrhage in outpatients taking warfarin.

Hylek EM, Singer DE. Hylek EM, et al. Among authors: singer de. Ann Intern Med. 1994 Jun 1;120(11):897-902. doi: 10.7326/0003-4819-120-11-199406010-00001. Ann Intern Med. 1994. PMID: 8172435

6

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

Hylek EM, Skates SJ, Sheehan MA, Singer DE. Hylek EM, et al. Among authors: singer de. N Engl J Med. 1996 Aug 22;335(8):540-6. doi: 10.1056/NEJM199608223350802. N Engl J Med. 1996. PMID: 8678931 Free article.

7

Acetaminophen and other risk factors for excessive warfarin anticoagulation.

Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Hylek EM, et al. Among authors: singer de. JAMA. 1998 Mar 4;279(9):657-62. doi: 10.1001/jama.279.9.657. JAMA. 1998. PMID: 9496982

8

Recent national patterns of warfarin use in atrial fibrillation.

Stafford RS, Singer DE. Stafford RS, et al. Among authors: singer de. Circulation. 1998 Apr 7;97(13):1231-3. doi: 10.1161/01.cir.97.13.1231. Circulation. 1998. PMID: 9570191

9

Rate control and sinus rhythm maintenance in atrial fibrillation: national trends in medication use, 1980-1996.

Stafford RS, Robson DC, Misra B, Ruskin J, Singer DE. Stafford RS, et al. Among authors: singer de. Arch Intern Med. 1998 Oct 26;158(19):2144-8. doi: 10.1001/archinte.158.19.2144. Arch Intern Med. 1998. PMID: 9801182

10

Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.

Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Go AS, et al. Among authors: singer de. Ann Intern Med. 1999 Dec 21;131(12):927-34. doi: 10.7326/0003-4819-131-12-199912210-00004. Ann Intern Med. 1999. PMID: 10610643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

448 results

Search Page